On July 28, 2020 Epizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, reported that management will host a conference call and webcast to discuss its second quarter 2020 financial results and other business highlights and will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference (Press release, Epizyme, JUL 28, 2020, View Source [SID1234562462]). Details of both events are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Second Quarter 2020 Financial Results: Management will host a conference call and webcast to discuss its second quarter 2020 financial results and other business highlights on Tuesday, Aug. 4, 2020 at 8:30 a.m. ET. To participate in the conference call, please dial (877) 844-6886 (domestic) or (970) 315-0315 (international) and refer to conference ID 5081295.

2020 Wedbush PacGrow Healthcare Virtual Conference: Epizyme will participate in the 2020 Wedbush PacGrow Healthcare Virtual Conference on Tuesday, Aug. 11, 2020, with a company overview to be presented at 9:45 a.m. ET.
Live webcasts will be available in the investor section of the company’s website at www.epizyme.com, and will be archived for 60 days following each event.